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INTRODUCTION
Allergic response to common environmental agents
(allergens) has been regarded as an important pathogenetic
mechanism of bronchial asthma (1). However, allergic sen-
sitization (atopy) cannot be detected in a significant number
of adult asthmatic patients (2). Traditionally, asthma has
been classified as atopic and nonatopic forms on the basis of
the presence or absence of immediate skin-test reactivity to
common aeroallergens (3). Atopic asthma usually starts dur-
ing childhood and is characterized by allergen-dependent,
often seasonal, symptoms (3, 4). In contrast, nonatopic asth-
ma usually begins in adulthood and is perennial and more
severe (3, 4). In addition, it is often associated with sinusitis
and nasal polyposis (3). Nonatopic asthma has been referred
to as  “intrinsic asthma”based on a suggestion that there
must be an etiologic agent in the patient’ s own body (3).
However, the  “intrinsic” etiology has not yet been defined.
The idea of a possible involvement of autoimmunity in
the pathogenesis of nonatopic asthma has been proposed by
previous studies which demonstrated higher incidences of
various autoantibodies including antinuclear and antithy-
roid antibodies in nonatopic asthmatics, as compared to
atopic asthmatics and healthy controls (5, 6). However, the
pathogenetic significance of these autoantibodies in nona-
topic asthma remains unexplained.
Bronchial epithelium has been suggested as a target for
inflammatory response in asthma (7). Presence of circulating
autoantibodies against lung and nasal mucosa tissues has
been reported in asthmatic patients by earlier studies (8, 9).
However, autoantigenic component of respiratory mucosa
tissue reacting with circulating autoantibodies is not still
defined. Recently, we showed the presence of circulating
IgG autoantibodies against bronchial epithelial cell in a
small portion of nonatopic asthma by indirect immunofluo-
rescence staining of human bronchial mucosa tissue (10).
To evaluate the possible involvement of autoimmune
response against bronchial epithelial cell in the pathogene-
sis of nonatopic asthma, we examined circulating autoanti-
bodies to cultured human bronchial epithelial cell in adult
patients with nonatopic asthma by enzyme-linked immuno-
sorbent assay (ELISA).
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Increased levels of Circulating Autoantibodies to Cultured Human
Bronchial Epithelial Cell in Adult Patients with Nonatopic Asthma
The pathogenetic mechanism of nonatopic asthma has not yet been defined.
The idea of a possible involvement of autoimmunity in the pathogenesis of
nonatopic asthma has been proposed by earlier studies. To evaluate the possi-
ble involvement of autoimmune response against bronchial epithelial cell in the
pathogenesis of nonatopic asthma, we measured circulating autoantibodies to
cultured human bronchial epithelial cell (BEAS-2B cell line) using enzyme-linked
immunosorbent assay. We used stored serum samples form 38 age-matched
healthy controls, 26 adult patients with atopic asthma, 16 adult patients with
nonatopic asthma, and 12 adult patients with systemic lupus erythematosus.
Levels of IgG autoantibodies to bronchial epithelial cell were significantly higher
in patients with nonatopic asthma (mean±SD of absorbance values; 0.135±
0.030) and systemic lupus erythematosus (0.293±0.181) than in healthy con-
trols (0.112±0.016) and patients with atopic asthma (0.116±0.031) (p<0.05).
This study showed that levels of circulating IgG autoantibodies to bronchial
epithelial cell were increased in adult patients with nonatopic asthma. Further
studies are needed to evaluate the possible involvement of autoimmune mecha-
nism in the pathogenesis of nonatopic asthma.
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PATIENTS AND METHODS
Patients
We used stored serum samples from 16 adult patients
with nonatopic asthma, 26 adult patients with atopic asthma,
38 age-matched healthy controls, and 12 adult patients
with systemic lupus erythematosus (Table 1). Asthmatic
subjects had typical clinical history of asthma and a 20%
decrease in forced expiratory volume in one second (FEV1)
following the inhalation of <8 mg methacholine/mL or
documented reversibility of FEV1 greater than 15% after
inhalation of bronchodilator. All subjects underwent skin-
prick test with 50 common aeroallergens including house
dust mites (Dermatophagoides farinae, Dermatophagoides
pteronyssinus), grass pollens, tree pollens, weed pollens, cat,
dog, and molds (Bencard Co., Brentford, UK). The wheal
diameters were measured after 15 min. Positive result of
skin-prick test was defined when wheal diameter of any
one allergen was greater than 3 mm over negative control
(normal saline). Atopic asthma was defined when skin-prick
test to any one allergen was positive. Nonatopic asthma
was defined when skin-prick test to any of the 50 common
aero-allergens was negative in the presence of a positive
histamine control. Patients with occupational asthma were
excluded from the study subjects. Patients with systemic
lupus erythematosus classified according to the criteria of
the American Rheumatic Association were included as a
positive control group for the measurement of autoanti-
bodies (11). Healthy controls had normal baseline lung
function and no clinical symptoms of respiratory diseases.
All sera were aliquoted and stored at -20℃. Serum total
IgE level was measured by radioimmunoassay using AlaS-
TAT kit (Diagnostic Product Corporation, Los Angeles,
CA). The institutional review board approved this study.
Cell culture
Human bronchial epithelial cell line (BEAS-2B) was ob-
tained from American Type Culture Collection (Rockville,
MD). BEAS-2B cells were cultured as previously described
(12).
Cell-ELISA
Circulating autoantibodies to cultured human bronchial
epithelial cell were measured by Cell-ELISA as previously
described with modification (13). BEAS-2B cells were cul-
tured in a 96-well tissue culture plate (Falcon, Franklin
Lakes, NJ). When monolayer of cells covered 50% of the
well, ELISA was conducted. After aspiration of culture
medium, the plates were incubated with duplicated serum
samples (100  L) diluted in culture medium at 1:500 (v/v)
dilution for 2 hr at 37℃ in CO2 incubator. The plates were
washed three times with Dulbecco’ s phosphate-buffered
saline. Then, the plates were incubated with peroxidase-
conjugated goat anti-human IgG antibodies (Sigma Chemi-
cal Co., St. Louis, MO) at 1:5000 dilution for 2 hr at 37℃
in CO2 incubator. The plates were washed three times
again. In the final step, the substrate solution consisting of
0.04% (w/v) o-phenylenediamine dissolved in 24.3 mM
citric acid, 51.4 mM NaH2PO4 (pH 5.0) and 0.03% H2O2
was added. After 30 min, the reaction was stopped by
adding 2.5 N H2SO4. Absorbance at 490 nm was measured
by a microplate reader. In each plate, 5 different serum sam-
ples were included for the measurement of variation. Coeffi-
cients of intraplate variation and interplate variation were
below 12%.
Statistical analyses
Data were expressed as mean±standard deviation (SD).
When multiple comparisons were made between groups,
significant between-group variability was first established
using the Kruskal-Wallis test. The Mann-Whitney U test
was then used to assess differences between two groups.
The Fisher’ s exact test was used to compare the frequencies
of autoantibodies between two groups. A p value of less
than 0.05 was considered significant.
RESUITS
Levels of IgG autoantibodies to bronchial epithelial cell
were significantly higher in patients with nonatopic asthma
(mean±SD of absorbance values; 0.135±0.030) and sys-
temic lupus erythematosus (0.293±0.181) than in healthy
FEV1 (% predicted) Age (yr) n Category Sex (F/M) Total IgE (IU/mL)
Healthy controls 38 38±10 22/16 275±329 104±18
�
Atopic asthma 26 24±9* 10/16 402±312* 78±19
Nonatopic asthma 16 42±15 11/5 73±82 76±18
Systemic lupus erythematosus 12 27±11 11/1 NM NM
Table 1. Characteristics of the study subjects 
Data are expressed as mean±standard deviation. NM: not measured. *Significant difference compared to healthy controls and nonatopic asthma
(p<0.05); 
� Significant difference compared to atopic and nonatopic asthma (p<0.05)Autoantibodies in Asthma 409
controls (0.112±0.016) and patients with atopic asthma
(0.116±0.031) (p<0.05, Fig. 1). When a positive response
was defined as greater than two standard deviations above
the mean of the healthy controls, IgG autoantibodies to
bronchial epithelial cell were positive in 7 (43.8%) of 16
patients with nonatopic asthma, 3 (11.5%) of 26 patients
with atopic asthma, 2 (5.3%) of 38 healthy controls, and 10
(83.3%) of 12 patients with systemic lupus erythematosus.
The positive rate of IgG autoantibodies to bronchial epithe-
lial cell was significantly higher in patients with nonatopic
asthma and systemic lupus erythematosus than in healthy
controls and atopic asthma (p<0.05, Table 2).
DISCUSSION
This study showed that levels of circulating autoantibod-
ies against the bronchial epithelial cell were increased in
adult patients with nonatopic asthma. This result suggests a
possible involvement of autoimmune response against
bronchial epithelial cell in patients with nonatopic asthma.
This interpretation is quite comparable with other chronic
inflammatory diseases involving epithelium such as pem-
phigus and ulcerative colitis, in which autoantibodies
against epithelial cell antigens of skin and colonic mucosa
were demonstrated (14, 15).
At present, the pathogenetic importance of autoantibod-
ies to bronchial epithelial cell is not certain. These autoanti-
bodies could be just a secondary phenomenon due to chron-
ic inflammation and immune response to newly exposed
self-antigens in the inflammatory process. However, the sig-
nificant difference of autoantibody levels between atopic
and nonatopic asthma goes against this explanation.
Recently, we examined the presence of circulating auto-
antibodies to human bronchial mucosa tissue by indirect
immunofluorescence staining method (10). We found auto-
antibodies to bronchial mucosa tissue in a small portion of
patients with nonatopic asthma (10). Isotype of autoanti-
bodies against bronchial mucosa tissue was mainly IgG and
these autoantibodies reacted predominantly with cytoplas-
mic membrane of basal cells in bronchial epithelium (10).
And the antigen-binding patterns of IgG autoantibodies in
patients with nonatopic asthma were different from those
patterns in patients with systemic lupus erythematosus
which showed predominant binding with the nucleus of
epithelial cells in whole layer of bronchial epithelium (10).
However, the prevalence of autoantibodies to bronchial epi-
thelial cell in nonatopic asthma was relatively low (9.1%)
and this result was interpreted as due in part to the insensi-
tive nature of indirect immunofluorescence staining method
and to the problem of nonspecific background staining (10).
In this study, we tried to quantify the levels of IgG autoan-
tibodies to bronchial epithelial cell using cell-ELISA tech-
nique and we found a higher prevalence (43.8%) of these
autoantibodies in nonatopic asthma.
There was a significant difference in levels of IgG autoanti-
bodies to bronchial epithelial cell between nonatopic asthma
and atopic asthma or healthy controls. However, the differ-
ences of mean absorbance values between nonatopic asthma
and atopic asthma or healthy controls were relatively small.
This result can be interpreted as follows: 1) the bronchial
epithelial autoantigens reacting with IgG autoantibodies
from nonatopic asthma are expressed in only a small amount
in bronchial epithelial cell; 2) the circulating IgG autoanti-
bodies to bronchial epithelial cell are present in a very small
amount in patients with nonatopic asthma; 3) lastly, the cir-
culating IgG autoantibodies to bronchial epithelial cell are
also present in healthy controls and patients with atopic asth-
ma but these autoantibodies react with different antigens on
bronchial epithelial cell. Further studies on the molecular
characterization of bronchial epithelial cell antigens reacting
with circulating IgG autoantibodies might be essential for
evaluating the importance of these autoantibodies in the
pathogenesis of nonatopic asthma.
Healthy controls 38 2 (5.3%)
Atopic asthma 26 3 (11.5%)
Nonatopic asthma 16 7 (43.8%)*
SLE 12 10 (83.3%)
�
n Category Number of positive results
Table 2. The positive rate of IgG autoantibodies to bronchial
epithelial cell
SLE: systemic lupus erythematosus. *Significant difference compared
to healthy controls and atopic asthma (p<0.05); 
� Significantly higher
positive rate compared to remaining 3 groups (p<0.05)
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Fig. 1. Levels of circulating IgG autoantibodies to human
bronchial epithelial cell in healthy controls, patients with atopic
asthma, nonatopic asthma, and systemic lupus erythematosus.
The horizontal line indicates mean absorbance+2 standard devi-
ations of healthy controls. Dotted lines indicate median values. 410 D.-H. Nahm, M.-J. Shin, H. Yim, et al.
Previous report suggested that there were fundamental
immunological differences between atopic and nonatopic
asthma in the patterns of T cell activation and cytokine pro-
duction (16). Asthma might just be a syndrome including
various heterogeneous diseases in regards to etiology, natu-
ral history, and severity, all of which have common physio-
logical characteristics of reversible airway obstruction. Our
study suggests a possible existence of asthmatic population
characterized by the presence of autoantibodies against
bronchial epithelial cell.
This study showed that circulating IgG autoantibodies
against the bronchial epithelial cell are increased in adult
patients with nonatopic asthma. Further studies are needed to
evaluate the possible involvement of autoimmune response
to bronchial epithelial cell in the pathogenesis of nonatopic
asthma.
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